Williams-Sonoma, Inc. · WSM · FY2026 Q1 · Calendar Q2 2026
Williams-Sonoma Q1 FY26: Broad Comp Growth, Margin Resilience, Dormify Launch
Williams-Sonoma opened fiscal 2026 with broad-based comparable revenue growth of 4.8% across all brands, an EPS beat of $1.93 versus $1.81 consensus, and an operating margin of 16.2% that held despite tariff and fuel cost pressure. The company maintained its full-year guidance (2%–6% revenue comp growth, 17.5%–18.1% operating margin), launched its 10th brand Dormify targeting dorm and small-space living, and deepened AI integration across personalization and design tools. Management returned $373 million to shareholders through buybacks and a 15% dividend increase, signaling confidence that brand momentum, supply-chain efficiency, and B2B strength can offset persistent macro and tariff uncertainty.
Company context
Snapshot as of publicationWilliams-Sonoma, Inc. (WSM) functions as a specialized, multi-channel retailer offering a diverse array of products for the home. Its flagship Williams Sonoma brand is renowned for cooking, dining, and entertaining essentials, such as cookware, culinary tools, small appliances, flatware, dinnerware, barware, outdoor furnishings, and an extensive collection of cookbooks. This brand also provides home furnishings and decorative accents. The popular Pottery Barn brand features furniture, bedding, lighting, rugs, table linens, and decorative items. Targeting younger demographics, Pottery Barn Kids offers children's accessories, while Pottery Barn Teen caters to adolescents with products ranging from organic bedding to versatile, multi-purpose furniture. Furthermore, West Elm contributes a selection of stylish home decor to the company's portfolio.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Neutral | Upgrade | Jul 27, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 7, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jun 23, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 22, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | May 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 22, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 22, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 22, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 12, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Apr 13, 2026 |
| TD Cowen | Buy | Buy | Maintain | Mar 19, 2026 |
| Baird | Outperform | Outperform | Maintain | Mar 19, 2026 |
| UBS | Neutral | Neutral | Maintain | Mar 11, 2026 |
| Zelman & Assoc | Neutral | Underperform | Upgrade | Jan 29, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 28, 2025 |
| Gordon Haskett | Buy | Hold | Upgrade | Jul 23, 2025 |
| Wedbush | Neutral | Neutral | Maintain | Mar 20, 2025 |
| Jefferies | Buy | Buy | Maintain | Mar 20, 2025 |
| Loop Capital | Hold | Hold | Maintain | Nov 21, 2024 |
| B of A Securities | Neutral | Neutral | Maintain | Mar 21, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Mar 15, 2024 |
| Guggenheim | Neutral | Neutral | Maintain | Mar 21, 2023 |
| Needham | Hold | Hold | Maintain | Dec 13, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Nov 18, 2022 |
| Credit Suisse | Underperform | Underperform | Maintain | Aug 26, 2021 |
| BNP Paribas | Neutral | Neutral | Maintain | Jul 16, 2021 |
| CFRA | Buy | Buy | Maintain | May 29, 2020 |
| Stifel | Hold | Hold | Maintain | Mar 20, 2020 |
| Argus Research | Buy | Buy | Maintain | Dec 2, 2019 |
| Citi | Neutral | Neutral | Maintain | May 31, 2019 |
| Berenberg | Hold | Hold | Maintain | May 9, 2019 |
| Deutsche Bank | Hold | Hold | Maintain | Nov 16, 2018 |
| Buckingham Research | Neutral | Neutral | Maintain | Nov 16, 2018 |
| Buckingham | Neutral | Neutral | Maintain | Nov 16, 2018 |
| Argus | Buy | Buy | Maintain | Aug 27, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Aug 23, 2018 |
| Moffett Nathanson | Neutral | Neutral | Maintain | Dec 4, 2017 |
| Bank of America | Underperform | Underperform | Maintain | Nov 17, 2017 |
| William Blair | Market Perform | Outperform | Downgrade | Mar 16, 2017 |
| Nomura | Buy | Buy | Maintain | Aug 25, 2016 |
| BTIG Research | Sell | Sell | Maintain | Aug 24, 2016 |
| BTIG | Sell | Sell | Maintain | Aug 24, 2016 |
| Topeka | Buy | Buy | Maintain | May 24, 2016 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 19, 2016 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Oct 12, 2015 |
| Cantor Fitzgerald | Hold | Hold | Maintain | Aug 27, 2015 |
| Canaccord Genuity | Hold | Hold | Maintain | Aug 27, 2015 |
| CRT Capital | Hold | Hold | Maintain | May 20, 2015 |
| BB&T Capital | Hold | Buy | Downgrade | Mar 19, 2015 |
| PiperJaffray | Neutral | Overweight | Downgrade | Feb 18, 2015 |
| Makor Capital | Sell | Sell | Maintain | Jul 17, 2014 |
| Barrington Research | Outperform | Outperform | Maintain | Jun 2, 2014 |
| Imperial Capital | In Line | In Line | Maintain | May 30, 2013 |
| Raymond James | Market Perform | Strong Buy | Downgrade | Jan 17, 2013 |
| ISI Group | Hold | Buy | Downgrade | Sep 27, 2012 |
| Bank oferica | Underperform | Underperform | Maintain | Mar 8, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $233.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Peter Keith | $253 | $226.74 | +8.4% | Jul 27, 2026 |
| KeyBanc | Analyst unavailable | $250 | $223.83 | +7.1% | Jul 7, 2026 |
| Argus Research | Christopher Graja | $230 | $205.58 | -1.4% | May 29, 2026 |
| Morgan Stanley | Analyst unavailable | $210 | $192.74 | -10.0% | May 22, 2026 |
| RBC Capital | Steven Shemesh | $192 | $193.32 | -17.7% | May 22, 2026 |
| Wells Fargo | Analyst unavailable | $190 | $191.94 | -18.6% | May 22, 2026 |
| Telsey Advisory | Cristina Fernandez | $225 | $191.94 | -3.6% | May 22, 2026 |
| Barclays | Analyst unavailable | $190 | $191.94 | -18.6% | May 22, 2026 |
| RBC Capital | Steven Shemesh | $191 | $171.38 | -18.2% | May 18, 2026 |
| Wells Fargo | Analyst unavailable | $185 | $172.06 | -20.7% | May 14, 2026 |
| Evercore ISI | Analyst unavailable | $200 | $193.52 | -14.3% | Apr 14, 2026 |
| Telsey Advisory | Cristina Fernandez | $220 | $188.8 | -5.7% | Mar 18, 2026 |
| Evercore ISI | Analyst unavailable | $215 | $220.73 | -7.9% | Feb 10, 2026 |
| Evercore ISI | Analyst unavailable | $210 | $214.03 | -10.0% | Feb 3, 2026 |
| RBC Capital | Analyst unavailable | $206 | $179.15 | -11.7% | Nov 21, 2025 |
| UBS | Michael Lasser | $175 | $176.83 | -25.0% | Nov 20, 2025 |
| Argus Research | Christopher Graja | $212 | $191.96 | -9.2% | Sep 2, 2025 |
| RBC Capital | Analyst unavailable | $213 | $188.06 | -8.7% | Aug 28, 2025 |
| UBS | Analyst unavailable | $200 | $188.06 | -14.3% | Aug 28, 2025 |
| KeyBanc | Bradley Thomas | $230 | $197.96 | -1.4% | Aug 25, 2025 |
| RBC Capital | Steven Shemesh | $182 | $157.85 | -22.0% | May 23, 2025 |
| Barclays | Seth Sigman | $166 | $174.28 | -28.9% | May 19, 2025 |
| Wedbush | Analyst unavailable | $190 | $194.58 | -18.6% | Feb 28, 2025 |
| Morgan Stanley | Simeon Gutman | $195 | $195.37 | -16.4% | Jan 21, 2025 |
| Jefferies | Jonathan Matuszewski | $156 | $131.63 | -33.2% | Sep 11, 2024 |
| Robert W. Baird | Peter Benedict | $140 | $136.67 | -40.0% | Aug 23, 2024 |
| RBC Capital | Scot Ciccarelli | $147 | $136.53 | -37.0% | Aug 23, 2024 |
| Wells Fargo | Zachary Fadem | $145 | $137.85 | -37.9% | Aug 19, 2024 |
| Barclays | Seth Sigman | $116 | $142.28 | -50.3% | May 23, 2024 |
| RBC Capital | Steven Shemesh | $150 | $140 | -35.7% | May 23, 2024 |
| Goldman Sachs | Kate McShane | $143.5 | $139.97 | -38.5% | May 23, 2024 |
| Telsey Advisory | Cristina Fernandez | $170 | $155.62 | -27.2% | Mar 25, 2024 |
| UBS | Atul Maheswari | $127.5 | $146.68 | -45.4% | Mar 19, 2024 |
| Goldman Sachs | Kate McShane | $131.5 | $139.95 | -43.6% | Mar 15, 2024 |
| RBC Capital | Scot Ciccarelli | $147.5 | $142.82 | -36.8% | Mar 14, 2024 |
| Wells Fargo | Zachary Fadem | $145 | $142.82 | -37.9% | Mar 14, 2024 |
| Telsey Advisory | Cristina Fernandez | $160 | $142.82 | -31.4% | Mar 14, 2024 |
| Evercore ISI | Oliver Wintermantel | $150 | $142.82 | -35.7% | Mar 14, 2024 |
| Morgan Stanley | Simeon Gutman | $135 | $142.82 | -42.1% | Mar 14, 2024 |
| Jefferies | Jonathan Matuszewski | $140 | $141.94 | -40.0% | Mar 13, 2024 |
| J.P. Morgan | Christopher Horvers | $145 | $241.06 | -37.9% | Mar 13, 2024 |
| Loop Capital Markets | Anthony Chukumba | $110 | $119.67 | -52.9% | Mar 5, 2024 |
| Wedbush | Seth Basham | $115 | $101.17 | -50.7% | Jan 11, 2024 |
| Telsey Advisory | Cristina Fernández | $73 | $66.91 | -68.7% | Aug 18, 2023 |
| Wedbush | Seth Basham | $60 | $66.09 | -74.3% | Aug 17, 2023 |
| Telsey Advisory | Cristina Fernández | $67.5 | $59.05 | -71.1% | May 18, 2023 |
| Telsey Advisory | Cristina Fernández | $71 | $59.21 | -69.6% | Mar 16, 2023 |
| Goldman Sachs | Analyst unavailable | $54.5 | $57.67 | -76.6% | Dec 12, 2022 |
| Morgan Stanley | Analyst unavailable | $50 | $61.21 | -78.6% | Nov 28, 2022 |
| Cowen & Co. | Analyst unavailable | $72.5 | $60.54 | -68.9% | Nov 18, 2022 |
| RBC Capital | Analyst unavailable | $75.5 | $65.19 | -67.6% | Nov 18, 2022 |
| Wells Fargo | Analyst unavailable | $60 | $65.19 | -74.3% | Nov 18, 2022 |
| Telsey Advisory | Analyst unavailable | $77.5 | $65.19 | -66.8% | Nov 18, 2022 |
| Jefferies | Jonathan Matuszewski | $50 | $58.81 | -78.6% | Oct 24, 2022 |
| Goldman Sachs | Analyst unavailable | $69 | $83 | -70.4% | Aug 26, 2022 |
| UBS | Analyst unavailable | $110 | $165.99 | -52.9% | Aug 25, 2022 |
| Goldman Sachs | Analyst unavailable | $50 | $59.93 | -78.6% | Jun 23, 2022 |
| UBS | Analyst unavailable | $50 | $52.63 | -78.6% | May 24, 2022 |
| Telsey Advisory | Cristina Fernandez | $41.25 | $27.04 | -82.3% | May 22, 2022 |
| Gordon Haskett Capital Corporation | Chuck Grom | $65 | $61.86 | -72.1% | May 6, 2022 |
| Morgan Stanley | Simeon Gutman | $85 | $72.79 | -63.6% | Mar 25, 2022 |
| Cowen & Co. | Max Rakhlenko | $112.5 | $80.35 | -51.8% | Mar 17, 2022 |
| Bank of America Securities | Elizabeth Lane Suzuki | $66 | $76.22 | -71.7% | Mar 16, 2022 |
| Robert W. Baird | Peter Benedict | $87.5 | $76.22 | -62.5% | Mar 16, 2022 |
| Wells Fargo | Zachary Fadem | $80 | $76.22 | -65.7% | Mar 16, 2022 |
| J.P. Morgan | Christopher Horvers | $80 | $70.57 | -65.7% | Mar 11, 2022 |
| Gordon Haskett Capital Corporation | Charles Grom | $100 | $79.01 | -57.1% | Feb 10, 2022 |
| Loop Capital Markets | Anthony Chukumba | $102.5 | $85.53 | -56.1% | Dec 22, 2021 |
| UBS | Michael Lasser | $75 | $104.74 | -67.9% | Nov 12, 2021 |
| Credit Suisse | Lavesh Hemnani | $77.5 | $92.54 | -66.8% | Aug 26, 2021 |
| Truist Financial | Scot Ciccarelli | $95.5 | $84.51 | -59.1% | May 27, 2021 |
| Jefferies | Jonathan Matuszewski | $80 | $84.51 | -65.7% | May 27, 2021 |
Track every rating change on WSM the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow WSM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Versus the prior quarter (Q4 FY2025), which closed a record fiscal year with full-year EPS of $8.84 and an 18.1% operating margin, Q1 FY26 demonstrated that momentum is carrying into the new year. Comparable revenue grew 4.8% with all brands positive, B2B accelerated to a record 13.7% growth, and the operating margin of 16.2% exceeded internal expectations despite higher tariff and fuel costs. The company launched Dormify as its 10th brand and expanded generative AI capabilities in its room-planner tool. FY26 guidance was left unchanged from the outlook issued in Q4. The stock responded with a 6.5% move on the report session and has drifted 17.8% higher since, on roughly 2.2x baseline volume.
Guidance delta
FY2026 guidance was maintained — unchanged from the initial outlook issued with Q4 FY2025 results. Management reaffirmed brand revenue comp growth of 2%–6% (midpoint 4%) and an operating margin range of 17.5%–18.1% (midpoint 17.8%). Capex remains approximately $275 million with an increasing trajectory, directed at e-commerce, retail, and supply-chain investments. No guidance was revised despite acknowledged tariff and fuel cost headwinds, reflecting management's confidence in offsetting cost pressures through supply-chain efficiency, AI-driven productivity, and brand pricing power.
Key takeaways
- Q1 comparable revenue grew 4.8% with all brands delivering positive comps.
- Operating margin of 16.2% exceeded expectations despite higher tariffs and fuel costs.
- EPS of $1.93 beat consensus by 6.6%; revenue of $1.81B edged past estimates by 0.4%.
- Returned $373M to shareholders via share repurchases and a 15% dividend increase.
- FY26 guidance unchanged: 2%–6% revenue growth, 17.5%–18.1% operating margin.
- B2B achieved record 13.7% growth; Dormify launched as the company's 10th brand.
Management priorities
- Further integration of AI into design tools, personalization, and customer experience platforms
- Rollout of new collaborations and product lines, including dorm-focused Dormify offerings
- Opening five new West Elm stores in 2026 with modest overall store count growth thereafter
- Continued capex investment of approximately $275M in e-commerce, retail, and supply chain for FY26
- Ongoing share repurchases and dividend increases to return excess cash to shareholders
Sources
- Earnings call transcript and parsed analysis · 2026-05-21T17:23:05.491042+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-30T16:01:15.741310+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T16:01:15.738427+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.